Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Application of TGA/c-DTA for Distinguishing between Two Forms of Naproxen in Pharmaceutical Preparations

P. Ramos, BK. Raczak, D. Silvestri, S. Wacławek

. 2023 ; 15 (6) : . [pub] 20230608

Status not-indexed Language English Country Switzerland

Document type Journal Article

Grant support
PCN-1-021/K/2/F Medical University of Silesia

Naproxen is one of the most used non-steroidal anti-inflammatory drugs (NSAIDs). It is used to treat pain of various origins, inflammation and fever. Pharmaceutical preparations containing naproxen are available with prescription and over-the-counter (OTC). Naproxen in pharmaceutical preparations is used in the form of acid and sodium salt. From the point of view of pharmaceutical analysis, it is crucial to distinguish between these two forms of drugs. There are many costly and laborious methods to do this. Therefore, new, faster, cheaper and, at the same time, simple-to-perform identification methods are sought. In the conducted studies, thermal methods such as thermogravimetry (TGA) supported by calculated differential thermal analysis (c-DTA) were proposed to identify the type of naproxen in commercially available pharmaceutical preparations. In addition, the thermal methods used were compared with pharmacopoeial methods for the identification of compounds, such as high-performance liquid chromatography (HPLC), Fourier-transform infrared spectroscopy (FTIR), UV-Vis spectrophotometry, and a simple colorimetric analyses. In addition, using nabumetone, a close structural analog of naproxen, the specificity of the TGA and c-DTA methods was assessed. Studies have shown that the thermal analyses used are effective and selective in distinguishing the form of naproxen in pharmaceutical preparations. This indicates the potential possibility of using TGA supported by c-DTA as an alternative method.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23009567
003      
CZ-PrNML
005      
20230721095538.0
007      
ta
008      
230707s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/pharmaceutics15061689 $2 doi
035    __
$a (PubMed)37376137
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Ramos, Paweł $u Department of Biophysics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jedności 8, 41-200 Sosnowiec, Poland $1 https://orcid.org/0000000300306002
245    10
$a Application of TGA/c-DTA for Distinguishing between Two Forms of Naproxen in Pharmaceutical Preparations / $c P. Ramos, BK. Raczak, D. Silvestri, S. Wacławek
520    9_
$a Naproxen is one of the most used non-steroidal anti-inflammatory drugs (NSAIDs). It is used to treat pain of various origins, inflammation and fever. Pharmaceutical preparations containing naproxen are available with prescription and over-the-counter (OTC). Naproxen in pharmaceutical preparations is used in the form of acid and sodium salt. From the point of view of pharmaceutical analysis, it is crucial to distinguish between these two forms of drugs. There are many costly and laborious methods to do this. Therefore, new, faster, cheaper and, at the same time, simple-to-perform identification methods are sought. In the conducted studies, thermal methods such as thermogravimetry (TGA) supported by calculated differential thermal analysis (c-DTA) were proposed to identify the type of naproxen in commercially available pharmaceutical preparations. In addition, the thermal methods used were compared with pharmacopoeial methods for the identification of compounds, such as high-performance liquid chromatography (HPLC), Fourier-transform infrared spectroscopy (FTIR), UV-Vis spectrophotometry, and a simple colorimetric analyses. In addition, using nabumetone, a close structural analog of naproxen, the specificity of the TGA and c-DTA methods was assessed. Studies have shown that the thermal analyses used are effective and selective in distinguishing the form of naproxen in pharmaceutical preparations. This indicates the potential possibility of using TGA supported by c-DTA as an alternative method.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Raczak, Barbara Klaudia $u Faculty of Mechatronics, Informatics and Interdisciplinary Studies, Technical University of Liberec, 461 17 Liberec, Czech Republic
700    1_
$a Silvestri, Daniele $u Institute for Nanomaterials, Advanced Technologies and Innovation, Technical University of Liberec, Stdentská 2, 460 01 Liberec, Czech Republic
700    1_
$a Wacławek, Stanisław $u Faculty of Mechatronics, Informatics and Interdisciplinary Studies, Technical University of Liberec, 461 17 Liberec, Czech Republic $u Institute for Nanomaterials, Advanced Technologies and Innovation, Technical University of Liberec, Stdentská 2, 460 01 Liberec, Czech Republic $1 https://orcid.org/0000000284308269
773    0_
$w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 15, č. 6 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37376137 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095531 $b ABA008
999    __
$a ok $b bmc $g 1958416 $s 1195831
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 15 $c 6 $e 20230608 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380
GRA    __
$a PCN-1-021/K/2/F $p Medical University of Silesia
LZP    __
$a Pubmed-20230707

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...